Communication of Benefits
This page lists 14 references in the Main Healthy Skepticism Library relevant to communication about the benefits of therapies.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL5577
Hu A, Chow CM, Dao D, Errett L, Keith M.
Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement.
J Cardiovasc Nurs 2006 May-Jun;21(3):169-75
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005082-200605000-00003
HSL5399
Dutta-Bergman MJ.
A formative approach to strategic message targeting through soap operas: using selective processing theories.
Health Commun 2006;19(1):11-8
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=4487&uid=16519588&db=PubMed&url=http://dx.doi.org/10.1207/s15327027hc1901_2
HSL2483
Mebane FE.
The importance of news media in pharmaceutical risk communication: proceedings of a workshop.
Pharmacoepidemiol Drug Saf 2005 May;14(5):297-306
http://www3.interscience.wiley.com/cgi-bin/abstract/109596257/ABSTRACT
HSL1842
Friedman R.
Mix Math and Medicine and Create Confusion
The New York Times 2005 Apr 26
HSL2210
Huh J, Cude BJ.
Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
J Health Commun 2004 Nov-Dec;9(6):529-40
http://journalsonline.tandf.co.uk/app/home/contribution.asp?wasp=97293d9777854ef4b987a516126c380c&referrer=parent&backto=issue,4,9;journal,5,49;linkingpublicationresults,1:100673,1
HSL2794
Jorgensen KJ, Gotzsche PC.
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.
BMJ 2004 Jan 17;328(7432):148
http://bmj.bmjjournals.com/cgi/content/full/328/7432/148
HSL2676
Lehner JP, Meyer F, Juillet Y.
[Communication and transparency concerning risk-benefit analysis in public health: the example of medication]
Therapie. 2001 Jul-Aug;56(4):335-9 2002 Jul-Aug 01;56(4):335-9
HSL2859
Hoye S, Hjortdahl P.
New wonder pill!--what do Norwegian newspapers write
2002 Jun 30;122(17):1671-6 2002 June 30;122(17):1671-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12555610
HSL856
Cooper RS.
Risks and benefits of calcium antagonists.
Lancet 1995 Oct 7;346(8980):961
HSL3134
Kline S.
Prescription drug advertising: Communicating risk, benefit and cost of pharmaceuticals
Canadian Public Health Association 1992 Feb 2-4:52-6
HSL3131
Lee PR, Lurie P, Silverman MM, Lydecker M.
Drug promotion and labeling in developing countries: an update.
J Clin Epidemiol 1991;44
HSL3827
Taylor D.
Effects of medical research on life expectancy.
Lancet 1986 Aug 16;2(8503):399-400
HSL3591
Osifo NG.
Overpromotion of drugs in international product package inserts.
Trop Doct 1983 Jan;13(1):5-8
HSL3305
Hendeles L.
Need for "counter-detailing" antibiotics.
Am J Hosp Pharm 1976 Sep;33(9):918-24